Long-term neurodevelopmental follow-up of children exposed to pravastatin in utero.
Costantine MM, Clifton RG, Boekhoudt TM, Lawrence K, Gyamfi-Bannerman C, Wisner KL, Grobman W, Caritis SN, Simhan HN, Hebert MF, Longo M, Saade GR; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network and the Obstetric-Fetal Pharmacology Research Centers Network.
Costantine MM, et al. Among authors: hebert mf.
Am J Obstet Gynecol. 2023 Aug;229(2):153.e1-153.e12. doi: 10.1016/j.ajog.2023.02.016. Epub 2023 Feb 24.
Am J Obstet Gynecol. 2023.
PMID: 36842489
BACKGROUND: Preeclampsia, especially before term, increases the risk of child neurodevelopmental adverse outcomes. ...Although the data were limited by the original trial's sample size, no identifiable long-term neurodevelopmental safety signal was evident with the …
BACKGROUND: Preeclampsia, especially before term, increases the risk of child neurodevelopmental adverse outcomes. ...Although the da …